Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST 2023-2030

UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST 2023-2030

The United States pharmaceutical supply chain management market is anticipated to register a CAGR of 8.84% during the forecast period of 2023-2030, capturing a revenue share of $1261.47 million by 2030.

UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST 2023-2030

United States Pharmaceutical Supply Chain Management Market by Component (Solution (Transportation Management System, Planning & Analytics, Warehouse & Inventory Management System, Procurement & Sourcing, Manufacturing Execution System), Service (Professional Services, Managed Services)) Market by Deployment Mode (on-premise, Cloud-based)

Request free sample

The United States pharmaceutical supply chain management market is anticipated to register a CAGR of 8.84% during the forecast period of 2023-2030, capturing a revenue share of $1261.47 million by 2030.

The country’s market growth is primarily attributed to key drivers, such as the increasing expenditure on pharmaceuticals, the high rates of digital transformation, and the surging adoption of innovative and cutting-edge technologies. Moreover, the increasing production of medicines and medical devices, leading to a higher demand for healthcare logistics, is expected to contribute to the United States pharmaceutical supply chain management market, as well.

United States Pharmaceutical Supply Chain Management MarketTo know more about this report, request a free sample copy

As per Atradius Insurance, the United States accounts for 45% of the global pharma market. Besides, from 2022 to 2023, the country’s pharmaceutical sector is projected to be fuelled by vaccinations in the post-COVID-19 period as well as the rising geriatric populace. Additionally, the United States healthcare industry spent $600 billion on prescription drugs, with an average of $442 spent on over-the-counter (OTC) medications by every household. This significant expenditure on pharmaceuticals marks a notable opportunity for the implementation of supply chain management mechanisms across the United States.

Digital transformation is highly valued by businesses operating in the United States. In this regard, they are typically considered the primary adopters of advanced technologies and solutions such as the Internet of Things (IoT), connected industries, additive manufacturing, artificial intelligence (AI), big data analytics, machine learning (ML), virtual reality (VR), and augmented reality (AR). Moreover, it also includes more recent telecommunications technologies like 4G, 5G, and LTE. The presence of leading pharmaceutical companies in the United States, such as Merck & Co Inc, AbbVie Inc, Johnson & Johnson, and Pfizer Inc, among others, coupled with a higher proclivity in terms of the adoption of new technologies, is set to aid in retaining the nation’s market dominance. As a result, these factors are projected to augment the United States pharmaceutical supply chain management market growth over the forecasting period.

The United States pharmaceutical supply chain management market is segmented into component and deployment mode. The deployment mode segment includes on-premise and cloud-based. Cloud-based applications, as well as platforms, are transforming supply chain management processes while scaling the operations of complex enterprises and small businesses. Moreover, cloud-based supply chain software solutions have recorded a substantial rise in implementation, mainly with a considerable surge in the growth of healthcare manufacturers.

Cloud-based platforms, such as ERP, also help increase the security as well as durability of essential healthcare information by offering out-of-the-box compliance with regulatory guidelines. Besides, with the surge in telehealth services, healthcare providers have also transitioned to cloud services in order to accelerate telehealth sessions.

The top enterprises operating in the United States pharmaceutical supply chain management market include McKesson Corporation, Oracle Corporation, Cardinal Health, etc.

Cardinal Health, headquartered in the United States, provides integrated healthcare products and services. The company supplies branded as well as generic drugs, over-the-counter healthcare and consumer products, specialty medicines, medical equipment, laboratory products, and surgical devices. Moreover, Cardinal Health also manufactures its privately branded surgical and medical products, in addition to offering effective solutions with an effective supply chain.

The company’s clientele includes retail customers, like chain and independent drug stores as well as pharmacies in supermarkets, mass merchandisers, ambulatory care centers, hospitals, clinical laboratories and alternative care providers, and physician offices.

Report Synopsis

Report Scope

Details
Market Forecast Years 2023-2030
Base Year 2022
Market Historical Years 2018-2022
Forecast Units Revenue ($ Million)
Segments Analyzed Component and Deployment Mode
Country Analyzed The United States
Companies Analyzed McKesson Corporation, Tecsys Inc, Infor, Oracle Corporation, Cardinal Health, SAP SE, Arvato Supply Chain Solutions, Terso Solution, Logitag Systems, Vizient Inc, Manhattan Associates, Spectrum Health, Epicor Software Corporation, Global Healthcare Exchange LLC, Jump Technologies

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
      • SCOPE OF STUDY
      • CRISIS SCENARIO ANALYSIS
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • INCREASING APPLICATION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
        • ADOPTION OF GS1 STANDARD SYSTEM
        • GROWING PRESSURE TO REDUCE HEALTHCARE COSTS
        • SURGING DEMAND FOR PHARMACEUTICALS PRODUCTS
        • HIGH PREVALENCE OF DRUG COUNTERFEITING IN THE PHARMA INDUSTRY
      • KEY RESTRAINTS
        • STRINGENT REGULATIONS IN HEALTHCARE DATA EXCHANGE
        • HIGH OPERATIONAL COSTS OF HEALTHCARE SCM SOFTWARE
        • TECHNICAL PROBLEMS ASSOCIATED WITH SCM SOFTWARE
        • SECURITY ISSUES IN WEAK SCM LINKS
    1. KEY ANALYTICS
      • KEY TECHNOLOGY TRENDS
      • PORTER’S FIVE FORCES
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • MARKET CONCENTRATION ANALYSIS
    2. MARKET BY COMPONENT
      • SOLUTION
        • TRANSPORTATION MANAGEMENT SYSTEM
        • PLANNING & ANALYTICS
        • WAREHOUSE & INVENTORY MANAGEMENT SYSTEM
        • PROCUREMENT & SOURCING
        • MANUFACTURING EXECUTION SYSTEM
      • SERVICE
        • PROFESSIONAL SERVICES
        • MANAGED SERVICES
    1. MARKET BY DEPLOYMENT MODE
      • ON-PREMISE
      • CLOUD-BASED
    2. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • PRODUCT LAUNCHES
        • PARTNERSHIPS
      • COMPANY PROFILES
        • CARDINAL HEALTH
          • COMPANY OVERVIEW
          • PRODUCTS / SERVICES LIST
          • STRENGTHS & CHALLENGES
        • INFOR
          • COMPANY OVERVIEW
          • PRODUCTS / SERVICES LIST
          • STRENGTHS & CHALLENGES
        • MANHATTAN ASSOCIATES
          • COMPANY OVERVIEW
          • PRODUCTS / SERVICES LIST
          • STRENGTHS & CHALLENGES
        • MCKESSON CORPORATION
          • COMPANY OVERVIEW
          • PRODUCTS / SERVICES LIST
          • STRENGTHS & CHALLENGES
        • ORACLE CORPORATION
          • COMPANY OVERVIEW
          • PRODUCTS / SERVICES LIST
          • STRENGTHS & CHALLENGES
        • SAP SE
          • COMPANY OVERVIEW
          • PRODUCTS / SERVICES LIST
          • STRENGTHS & CHALLENGES
        • TECSYS INC
          • COMPANY OVERVIEW
          • PRODUCTS / SERVICES LIST
          • STRENGTHS & CHALLENGES

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT

    TABLE 2: PRIMARY FACTORS CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS

    TABLE 3: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

    TABLE 4: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2023-2030 (IN $ MILLION)

    TABLE 5: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

    TABLE 6: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, FORECAST YEARS, 2023-2030 (IN $ MILLION)

    TABLE 7: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

    TABLE 8: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, FORECAST YEARS, 2023-2030 (IN $ MILLION)

    TABLE 9: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

    TABLE 10: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, FORECAST YEARS, 2023-2030 (IN $ MILLION)

    TABLE 11: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK

    TABLE 12: LIST OF PRODUCT LAUNCHES

    TABLE 13: LIST OF PARTNERSHIPS

    LIST OF FIGURES

    FIGURE 1: KEY TECHNOLOGY TRENDS

    FIGURE 2: PORTER’S FIVE FORCES

    FIGURE 3: MARKET CONCENTRATION ANALYSIS

    FIGURE 4: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2022

    FIGURE 5: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030 (IN $ MILLION)

    FIGURE 6: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SOLUTION, IN 2022

    FIGURE 7: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION MANAGEMENT SYSTEM, 2023-2030 (IN $ MILLION)

    FIGURE 8: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING & ANALYTICS, 2023-2030 (IN $ MILLION)

    FIGURE 9: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE & INVENTORY MANAGEMENT SYSTEM, 2023-2030 (IN $ MILLION)

    FIGURE 10: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT & SOURCING, 2023-2030 (IN $ MILLION)

    FIGURE 11: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING EXECUTION SYSTEM, 2023-2030 (IN $ MILLION)

    FIGURE 12: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN $ MILLION)

    FIGURE 13: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2022

    FIGURE 14: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES, 2023-2030 (IN $ MILLION)

    FIGURE 15: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES, 2023-2030 (IN $ MILLION)

    FIGURE 16: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODE, IN 2022

    FIGURE 17: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2030 (IN $ MILLION)

    FIGURE 18: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2030 (IN $ MILLION)       

    1. MARKET BY COMPONENT
      • SOLUTION
        • TRANSPORTATION MANAGEMENT SYSTEM
        • PLANNING & ANALYTICS
        • WAREHOUSE & INVENTORY MANAGEMENT SYSTEM
        • PROCUREMENT & SOURCING
        • MANUFACTURING EXECUTION SYSTEM
      • SERVICE
        • PROFESSIONAL SERVICES
        • MANAGED SERVICES
    1. MARKET BY DEPLOYMENT MODE
      • ON-PREMISE
      • CLOUD-BASED

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type